Autoimmunity resulting from cytokine treatment predicts long-term survival in patients with metastatic renal cell cancer

Journal of Clinical Oncology

Volumn 17, Issue 2, 1999, Pages 529-533

  Franzke, Anke ^a   Peest, Dietrich ^a   Probst Kepper, Michael ^a   Buer, Jan ^a   Kirchner, Gabriele I ^a   Brabant, Georg ^a   Kirchner, Hartmut ^a   Ganser, Arnold ^a   Atzpodien, Jens ^a  

^a HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; AUTOANTIBODY; CYTOKINE; HLA ANTIGEN CLASS 1; INTERLEUKIN 2; THYROGLOBULIN ANTIBODY; THYROID ANTIBODY; TUMOR MARKER;

ADULT; ARTICLE; AUTOIMMUNITY; CANCER CONTROL; CANCER IMMUNOTHERAPY; CANCER SURVIVAL; CONTROLLED STUDY; CORRELATION FUNCTION; DISEASE ASSOCIATION; FEMALE; GENETIC PREDISPOSITION; HUMAN; HYPERTHYROIDISM; HYPOTHYROIDISM; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY CARCINOMA; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; PRIORITY JOURNAL; PROGNOSIS; THYROID DISEASE;

EID: 0033014677     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/jco.1999.17.2.529     Document Type: Article

References (24)

1. Rosenberg SA, Lotze MT, Muul LM, et al: A progress report on treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone. N Engl J Med 316:889-897, 1987
2. Atzpodien J, Lopez Hänninen E, Kirchner H, et al: Multiinstitutional home-therapy trial of recombinant human interleukin-2 and interferon alpha-2 in progressive metastatic renal cell carcinoma. J Clin Oncol 13:497-501, 1995
3. Facendola G, Locatelli MC, Pizzocaro G, et al: Subcutaneous administration of interleukin-2 and interferon-alpha-2b in advanced renal cell carcinoma: A confirmatory study. Br J Cancer 72:1531-1535, 1995
4. Atkins MB, Mier JW, Parkinson DP, et al: Hypothyroidism after treatment with interleukin-2 and lymphokine-activated killer cells. N Engl J Med 318:1557-1562, 1988
5. Weijl NI, Van Der Harst D, Brand A, et al: Hypothyroidism during immunotherapy with interleukin-2 is associated with antithyroid antibodies and response to treatment. J Clin Oncol 11:1376-1383, 1993
6. Scalzo S, Gengaro A, Boccoli G, et al: Primary hypothyroidism associated with interleukin-2 and interferon alpha-2 therapy of melanoma and renal carcinoma. Eur J Cancer 26:1152-1156, 1990
7. Sauter NP, Sauter MD, Atkins MB, et al: Transient thyrotoxicosis and persistent hypothyroidism due to acute autoimmune thyroiditis after interleukin-2 and interferon-alpha therapy for metastatic carcinoma: A case report. Am J Med 92:441-444, 1992
8. Lopez Hänninen E, Kirchner H, Atzpodien J: Interleukin-2 based home therapy of metastatic renal cell carcinoma: Risk and benefits in 215 consecutive single institution patients. J Urol 155:19-25, 1995
9. Cox DR: Regression models and life-tables. J R Stat Soc (B) 34:187-220, 1972
10. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457-481, 1958
11. Strakosh CR, Wenzel BE, Row VV, et al: Immunology of autoimmune thyroid diseases. N Engl J Med 307:1499-1507, 1982
12. Canonica GW, Cosulich ME, Croci R, et al: Thyreoglobulin-induced T cell in vitro proliferation in Hashimoto's thyroiditis: Identification of the responsive subset and effect of monoclonal antibodies directed to Ia antigens. Clin Immunol Immunopathol 32:142-151, 1984
13. Volpe R: Immunology of human thyroid disease, in Volpe R (ed): Autoimmunity in Endocrine Disease. Boca Raton, FL, CRC Press, 1986, pp 73-98
14. Margolick JB, Hsu SM, Volkman DJ, et al: Immunohistochemical characterization of intrathyroid lymphocytes in Graves' disease: Interstitial and intraepithelial populations. Am J Med 76:815-821, 1984
15. Bottazzo GF, Pujol-Borrell R, Hanafusa T, et al: Role of aberrant HLA-DR expression and antigen presentation in induction of endocrine autoimmunity. Lancet 2:1115-1119, 1983
16. Todd I, Pujol-Borrell R, Hammond LJ, et al: HLA-DR expression by thyroid epithelium. Clin Exp Immunol 61:265-273, 1985
17. Honda K, Tamai H, Morita T, et al: Hashimoto's thyroiditis and HLA in Japanese. J Clin Endocrinol Metab 69:1268-1273, 1989
18. Tamai H, Uno H, Hirota Y, et al: Immunogenetics of Hashimoto's and Graves' disease. J Clin Endocrinol Metab 60:62-66, 1985
19. Uno H, Sasazuki T, Tamai H, et al: Two major genes, linked to HLA and Gm, control susceptibility to Graves' disease. Nature 292:768-770, 1981
20. Heath WR, Allison J, Hoffmann MW, et al: Autoimmune diabetes as a consequence of locally produced IL-2. Nature 359:547-549, 1992
21. Hashimoto's thyroiditis: A disease of autoimmunity, in DeGroot LJ, Larsen PR, Refetott S, et al (eds): The Thyroid and Its Diseases (ed 5). New York, NY, John Wiley Publications, 1984
22. Baur MP: Population analysis on the basis of deduced haplotypes from random families, in Albert ED, Baur MP, Mayr WR (eds): Histocompatibility Testing 1984. New York, NY, Springer Verlag, 1984
23. Tiwari JL, Terasaki PI (eds): HLA and Disease Associations. New York, NY, Springer Verlag, 1985
24. Leidenius MH, Koskimies SA, Kellokumpu IH, et al: HLA antigens in ulcerative colitis and primary sclerosing cholangitis. APMIS 103:519-524, 1995